StockData
Shuttle Pharmaceuticals Holdings, Inc. logo

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock

SHPHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 24, 2026Score 5/30
$4.24−0.29 (-6.40%)

Close on Nov 16, 2026Market cap $4.24MP/E –Yield –

Shuttle Pharmaceuticals cash

Cash and short-term investments held at the end of each period.

Shuttle Pharmaceuticals's cash was $90.24K at Jun 30, 2026. For fiscal 2025 it was $334.01K, down 82.6% from the year before. The highest annual figure on record is $8.42M in fiscal 2022.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$334.01K-82.6%
FY2024Dec 31, 2024$1.92M-64.9%
FY2023Dec 31, 2023$5.46M-35.1%
FY2022Dec 31, 2022$8.42M+1567.6%
FY2021Dec 31, 2021$504.75K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$90.24K-98.1%
Q1 FY2026Mar 31, 2026$1.09M-75.8%
Q4 FY2025Dec 31, 2025$334.01K-82.6%
Q3 FY2025Sep 30, 2025$2.09M+1237.1%
Q2 FY2025Jun 30, 2025$4.82M+106.0%
Q1 FY2025Mar 31, 2025$4.51M+7.8%
Q4 FY2024Dec 31, 2024$1.92M-64.9%
Q3 FY2024Sep 30, 2024$156.66K-97.7%
Q2 FY2024Jun 30, 2024$2.34M-72.0%
Q1 FY2024Mar 31, 2024$4.19M-58.8%
Q4 FY2023Dec 31, 2023$5.46M-35.1%
Q3 FY2023Sep 30, 2023$6.81M-25.4%
Q2 FY2023Jun 30, 2023$8.35M+1554.5%
Q1 FY2023Mar 31, 2023$10.16M–
Q4 FY2022Dec 31, 2022$8.42M–
Q3 FY2022Sep 30, 2022$9.12M–
Q4 FY2021Dec 31, 2021$504.75K–

More Shuttle Pharmaceuticals figures

See a number that looks wrong?